Loading
Latest filing published 29 May 2026 for 바이오노트, €5,665.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by 박철세 on record concern 바이오노트, in the capacity of board member. In total, 2 filings cover trades dated from 5 March 2026 to 27 May 2026.
Purchases make up the whole of the open-market record (2 purchases, €18k). Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 29 May 2026, reports an open-market purchase of €5,665 in 바이오노트. Every figure here comes from the filings published by DART (FSS) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.